 | • レポートコード：MRC2Q12-19485 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、フェニル酪酸ナトリウムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 フェニル酪酸ナトリウムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フェニル酪酸ナトリウムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フェニル酪酸ナトリウムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのフェニル酪酸ナトリウムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のフェニル酪酸ナトリウムの売上および2028年までの予測に焦点を当てています。 フェニル酪酸ナトリウムのグローバル主要企業には、Lee's Pharmaceutical、Amylyx Pharma、Medunik、Par Pharma、Sigmapharm Laboratories、Alvogen、Horizon Therapeutics、Tobio Novelfarma、Orpharma、Investor ABなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フェニル酪酸ナトリウム市場は、タイプとアプリケーションによって区分されます。世界のフェニル酪酸ナトリウム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、顆粒剤、散剤 【アプリケーション別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フェニル酪酸ナトリウム製品概要 - タイプ別市場（錠剤、顆粒剤、散剤） - アプリケーション別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフェニル酪酸ナトリウム販売量予測2017-2028 - 世界のフェニル酪酸ナトリウム売上予測2017-2028 - フェニル酪酸ナトリウムの地域別販売量 - フェニル酪酸ナトリウムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フェニル酪酸ナトリウム販売量 - 主要メーカー別フェニル酪酸ナトリウム売上 - 主要メーカー別フェニル酪酸ナトリウム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、顆粒剤、散剤） - フェニル酪酸ナトリウムのタイプ別販売量 - フェニル酪酸ナトリウムのタイプ別売上 - フェニル酪酸ナトリウムのタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、その他） - フェニル酪酸ナトリウムのアプリケーション別販売量 - フェニル酪酸ナトリウムのアプリケーション別売上 - フェニル酪酸ナトリウムのアプリケーション別価格 ・北米市場 - 北米のフェニル酪酸ナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフェニル酪酸ナトリウム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフェニル酪酸ナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフェニル酪酸ナトリウム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフェニル酪酸ナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフェニル酪酸ナトリウム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフェニル酪酸ナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフェニル酪酸ナトリウム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフェニル酪酸ナトリウム市場規模（タイプ別、アプリケーション別） - 主要国別のフェニル酪酸ナトリウム市場規模（トルコ、サウジアラビア） ・企業情報 Lee's Pharmaceutical、Amylyx Pharma、Medunik、Par Pharma、Sigmapharm Laboratories、Alvogen、Horizon Therapeutics、Tobio Novelfarma、Orpharma、Investor AB ・産業チェーン及び販売チャネル分析 - フェニル酪酸ナトリウムの産業チェーン分析 - フェニル酪酸ナトリウムの原材料 - フェニル酪酸ナトリウムの生産プロセス - フェニル酪酸ナトリウムの販売及びマーケティング - フェニル酪酸ナトリウムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フェニル酪酸ナトリウムの産業動向 - フェニル酪酸ナトリウムのマーケットドライバー - フェニル酪酸ナトリウムの課題 - フェニル酪酸ナトリウムの阻害要因 ・主な調査結果 |
Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sodium Phenylbutyrate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sodium Phenylbutyrate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sodium Phenylbutyrate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sodium Phenylbutyrate include Lee’s Pharmaceutical, Amylyx Pharma, Medunik, Par Pharma, Sigmapharm Laboratories, Alvogen, Horizon Therapeutics, Tobio Novelfarma and Orpharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sodium Phenylbutyrate manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sodium Phenylbutyrate market. Further, it explains the major drivers and regional dynamics of the global Sodium Phenylbutyrate market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lee’s Pharmaceutical
Amylyx Pharma
Medunik
Par Pharma
Sigmapharm Laboratories
Alvogen
Horizon Therapeutics
Tobio Novelfarma
Orpharma
Investor AB
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Sodium Phenylbutyrate Segment by Dosage Form
Tablets
Granules
Powder
Sodium Phenylbutyrate Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sodium Phenylbutyrate market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sodium Phenylbutyrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sodium Phenylbutyrate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sodium Phenylbutyrate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sodium Phenylbutyrate sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sodium Phenylbutyrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sodium Phenylbutyrate sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lee’s Pharmaceutical, Amylyx Pharma, Medunik, Par Pharma, Sigmapharm Laboratories, Alvogen, Horizon Therapeutics, Tobio Novelfarma and Orpharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sodium Phenylbutyrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Sodium Phenylbutyrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sodium Phenylbutyrate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Sodium Phenylbutyrate Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Sodium Phenylbutyrate Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Granules
1.2.4 Powder
1.3 Market by Application
1.3.1 Global Sodium Phenylbutyrate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sodium Phenylbutyrate Sales Estimates and Forecasts 2017-2028
2.2 Global Sodium Phenylbutyrate Revenue Estimates and Forecasts 2017-2028
2.3 Global Sodium Phenylbutyrate Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sodium Phenylbutyrate Sales by Region
2.4.1 Global Sodium Phenylbutyrate Sales by Region (2017-2022)
2.4.2 Global Sales Sodium Phenylbutyrate by Region (2023-2028)
2.5 Global Sodium Phenylbutyrate Revenue by Region
2.5.1 Global Sodium Phenylbutyrate Revenue by Region (2017-2022)
2.5.2 Global Sodium Phenylbutyrate Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sodium Phenylbutyrate Sales by Manufacturers
3.1.1 Global Top Sodium Phenylbutyrate Manufacturers by Sales (2017-2022)
3.1.2 Global Sodium Phenylbutyrate Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sodium Phenylbutyrate in 2021
3.2 Global Sodium Phenylbutyrate Revenue by Manufacturers
3.2.1 Global Sodium Phenylbutyrate Revenue by Manufacturers (2017-2022)
3.2.2 Global Sodium Phenylbutyrate Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sodium Phenylbutyrate Revenue in 2021
3.3 Global Sodium Phenylbutyrate Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sodium Phenylbutyrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sodium Phenylbutyrate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Sodium Phenylbutyrate Sales by Dosage Form
4.1.1 Global Sodium Phenylbutyrate Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Sodium Phenylbutyrate Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Sodium Phenylbutyrate Sales Market Share by Dosage Form (2017-2028)
4.2 Global Sodium Phenylbutyrate Revenue by Dosage Form
4.2.1 Global Sodium Phenylbutyrate Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Sodium Phenylbutyrate Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Sodium Phenylbutyrate Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Sodium Phenylbutyrate Price by Dosage Form
4.3.1 Global Sodium Phenylbutyrate Price by Dosage Form (2017-2022)
4.3.2 Global Sodium Phenylbutyrate Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Sodium Phenylbutyrate Sales by Application
5.1.1 Global Sodium Phenylbutyrate Historical Sales by Application (2017-2022)
5.1.2 Global Sodium Phenylbutyrate Forecasted Sales by Application (2023-2028)
5.1.3 Global Sodium Phenylbutyrate Sales Market Share by Application (2017-2028)
5.2 Global Sodium Phenylbutyrate Revenue by Application
5.2.1 Global Sodium Phenylbutyrate Historical Revenue by Application (2017-2022)
5.2.2 Global Sodium Phenylbutyrate Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sodium Phenylbutyrate Revenue Market Share by Application (2017-2028)
5.3 Global Sodium Phenylbutyrate Price by Application
5.3.1 Global Sodium Phenylbutyrate Price by Application (2017-2022)
5.3.2 Global Sodium Phenylbutyrate Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sodium Phenylbutyrate Market Size by Dosage Form
6.1.1 North America Sodium Phenylbutyrate Sales by Dosage Form (2017-2028)
6.1.2 North America Sodium Phenylbutyrate Revenue by Dosage Form (2017-2028)
6.2 North America Sodium Phenylbutyrate Market Size by Application
6.2.1 North America Sodium Phenylbutyrate Sales by Application (2017-2028)
6.2.2 North America Sodium Phenylbutyrate Revenue by Application (2017-2028)
6.3 North America Sodium Phenylbutyrate Market Size by Country
6.3.1 North America Sodium Phenylbutyrate Sales by Country (2017-2028)
6.3.2 North America Sodium Phenylbutyrate Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Sodium Phenylbutyrate Market Size by Dosage Form
7.1.1 Europe Sodium Phenylbutyrate Sales by Dosage Form (2017-2028)
7.1.2 Europe Sodium Phenylbutyrate Revenue by Dosage Form (2017-2028)
7.2 Europe Sodium Phenylbutyrate Market Size by Application
7.2.1 Europe Sodium Phenylbutyrate Sales by Application (2017-2028)
7.2.2 Europe Sodium Phenylbutyrate Revenue by Application (2017-2028)
7.3 Europe Sodium Phenylbutyrate Market Size by Country
7.3.1 Europe Sodium Phenylbutyrate Sales by Country (2017-2028)
7.3.2 Europe Sodium Phenylbutyrate Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sodium Phenylbutyrate Market Size by Dosage Form
8.1.1 Asia Pacific Sodium Phenylbutyrate Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Sodium Phenylbutyrate Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Sodium Phenylbutyrate Market Size by Application
8.2.1 Asia Pacific Sodium Phenylbutyrate Sales by Application (2017-2028)
8.2.2 Asia Pacific Sodium Phenylbutyrate Revenue by Application (2017-2028)
8.3 Asia Pacific Sodium Phenylbutyrate Market Size by Region
8.3.1 Asia Pacific Sodium Phenylbutyrate Sales by Region (2017-2028)
8.3.2 Asia Pacific Sodium Phenylbutyrate Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Sodium Phenylbutyrate Market Size by Dosage Form
9.1.1 Latin America Sodium Phenylbutyrate Sales by Dosage Form (2017-2028)
9.1.2 Latin America Sodium Phenylbutyrate Revenue by Dosage Form (2017-2028)
9.2 Latin America Sodium Phenylbutyrate Market Size by Application
9.2.1 Latin America Sodium Phenylbutyrate Sales by Application (2017-2028)
9.2.2 Latin America Sodium Phenylbutyrate Revenue by Application (2017-2028)
9.3 Latin America Sodium Phenylbutyrate Market Size by Country
9.3.1 Latin America Sodium Phenylbutyrate Sales by Country (2017-2028)
9.3.2 Latin America Sodium Phenylbutyrate Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Sodium Phenylbutyrate Market Size by Dosage Form
10.1.1 Middle East and Africa Sodium Phenylbutyrate Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Sodium Phenylbutyrate Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Sodium Phenylbutyrate Market Size by Application
10.2.1 Middle East and Africa Sodium Phenylbutyrate Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sodium Phenylbutyrate Revenue by Application (2017-2028)
10.3 Middle East and Africa Sodium Phenylbutyrate Market Size by Country
10.3.1 Middle East and Africa Sodium Phenylbutyrate Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sodium Phenylbutyrate Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lee’s Pharmaceutical
11.1.1 Lee’s Pharmaceutical Corporation Information
11.1.2 Lee’s Pharmaceutical Overview
11.1.3 Lee’s Pharmaceutical Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lee’s Pharmaceutical Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lee’s Pharmaceutical Recent Developments
11.2 Amylyx Pharma
11.2.1 Amylyx Pharma Corporation Information
11.2.2 Amylyx Pharma Overview
11.2.3 Amylyx Pharma Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amylyx Pharma Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amylyx Pharma Recent Developments
11.3 Medunik
11.3.1 Medunik Corporation Information
11.3.2 Medunik Overview
11.3.3 Medunik Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medunik Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medunik Recent Developments
11.4 Par Pharma
11.4.1 Par Pharma Corporation Information
11.4.2 Par Pharma Overview
11.4.3 Par Pharma Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Par Pharma Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Par Pharma Recent Developments
11.5 Sigmapharm Laboratories
11.5.1 Sigmapharm Laboratories Corporation Information
11.5.2 Sigmapharm Laboratories Overview
11.5.3 Sigmapharm Laboratories Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sigmapharm Laboratories Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sigmapharm Laboratories Recent Developments
11.6 Alvogen
11.6.1 Alvogen Corporation Information
11.6.2 Alvogen Overview
11.6.3 Alvogen Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Alvogen Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alvogen Recent Developments
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Corporation Information
11.7.2 Horizon Therapeutics Overview
11.7.3 Horizon Therapeutics Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Horizon Therapeutics Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Horizon Therapeutics Recent Developments
11.8 Tobio Novelfarma
11.8.1 Tobio Novelfarma Corporation Information
11.8.2 Tobio Novelfarma Overview
11.8.3 Tobio Novelfarma Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tobio Novelfarma Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tobio Novelfarma Recent Developments
11.9 Orpharma
11.9.1 Orpharma Corporation Information
11.9.2 Orpharma Overview
11.9.3 Orpharma Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Orpharma Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Orpharma Recent Developments
11.10 Investor AB
11.10.1 Investor AB Corporation Information
11.10.2 Investor AB Overview
11.10.3 Investor AB Sodium Phenylbutyrate Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Investor AB Sodium Phenylbutyrate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Investor AB Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sodium Phenylbutyrate Industry Chain Analysis
12.2 Sodium Phenylbutyrate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sodium Phenylbutyrate Production Mode & Process
12.4 Sodium Phenylbutyrate Sales and Marketing
12.4.1 Sodium Phenylbutyrate Sales Channels
12.4.2 Sodium Phenylbutyrate Distributors
12.5 Sodium Phenylbutyrate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sodium Phenylbutyrate Industry Trends
13.2 Sodium Phenylbutyrate Market Drivers
13.3 Sodium Phenylbutyrate Market Challenges
13.4 Sodium Phenylbutyrate Market Restraints
14 Key Findings in The Global Sodium Phenylbutyrate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer